Theo Schetters studied Biology at Utrecht University in the Netherlands.  After graduation in 1980 he was employed at the Department of Immunology of the Veterinary Faculty of the University of Utrecht where he worked on the antigenic diversity of Trypanosoma parasites. From 1981 to 1987 he worked at the Department of Cytology and Histology at the University of Nijmegen in the Netherlands where he studied immune responsiveness of mice against Plasmodium berghei infection. This work was awarded with the Laveran Medal of the Fondation Merieux (Annecy, France). In 1986 he obtained a PhD in Medicine from Nijmegen University in the Netherlands, and received a visiting scientist award from the Royal Society (London) to work on malaria immunology at the National Institute for Medical Research in Mill Hill, London (UK). Since 1988 he is employed at the Parasitology R&D Department of Intervet International (Boxmeer, The Netherlands). His main interest is the development of vaccines against protozoal infections. He has developed a vaccine against coccidiosis in chickens (Nobilis® Cox ATM) and a vaccine against Babesia infections in dogs (Nobivac® Piro). In 2004 he received the Medal of Honour of the Faculty of Pharmacy, University of Montpellier 1 in France and was bestowed Professeur Invité as recognition for his contribution to longstanding collaborative research with the Laboratory of Cellular and Molecular Biology of the University (head Prof. Andre Gorenflot). Theo Schetters is editorial board member of Veterinary Parasitology (Elseviers Science Publishers) and Parasitology (Cambridge University Press). He has published over 60 scientific research articles.